BindingDB logo
myBDB logout

BDBM140141 US8901315, 274

SMILES: Cc1nn(C2CCCCC2)c2sc(cc12)C(=O)N[C@H]1CC[C@@H](CC1)N1CCCS1(=O)=O

InChI Key: InChIKey=NSNPLHLWMMBOPL-QAQDUYKDSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 140141   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Phosphodiesterase 4 (PDE4)


(Mus musculus (Mouse))
BDBM140141
PNG
(US8901315, 274)
Show SMILES Cc1nn(C2CCCCC2)c2sc(cc12)C(=O)N[C@H]1CC[C@@H](CC1)N1CCCS1(=O)=O |r,wU:18.20,wD:21.27,(-6.96,4.1,;-6.19,2.77,;-7.1,1.52,;-6.19,.27,;-6.59,-1.21,;-8.08,-1.61,;-8.48,-3.1,;-7.39,-4.19,;-5.9,-3.79,;-5.5,-2.3,;-4.73,.75,;-3.27,.27,;-2.36,1.52,;-3.27,2.77,;-4.73,2.29,;-.82,1.52,;-.05,.19,;-.05,2.85,;1.49,2.85,;2.26,4.19,;3.8,4.19,;4.57,2.85,;3.8,1.52,;2.26,1.52,;6.11,2.85,;7.01,4.1,;8.48,3.62,;8.48,2.08,;7.01,1.61,;6.24,.27,;7.78,.27,)|
Show InChI InChI=1S/C22H32N4O3S2/c1-15-19-14-20(30-22(19)26(24-15)18-6-3-2-4-7-18)21(27)23-16-8-10-17(11-9-16)25-12-5-13-31(25,28)29/h14,16-18H,2-13H2,1H3,(H,23,27)/t16-,17-
PDB

KEGG

UniProtKB/TrEMBL

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 1.70E+3n/an/an/an/a6.54



Daiichi Sankyo Company, Limited

US Patent


Assay Description
The PDE 4 (phosphodiesterase IV) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifie...


US Patent US8901315 (2014)


BindingDB Entry DOI: 10.7270/Q2GM860P
More data for this
Ligand-Target Pair
Phosphodiesterase 7


(Homo sapiens (Human))
BDBM140141
PNG
(US8901315, 274)
Show SMILES Cc1nn(C2CCCCC2)c2sc(cc12)C(=O)N[C@H]1CC[C@@H](CC1)N1CCCS1(=O)=O |r,wU:18.20,wD:21.27,(-6.96,4.1,;-6.19,2.77,;-7.1,1.52,;-6.19,.27,;-6.59,-1.21,;-8.08,-1.61,;-8.48,-3.1,;-7.39,-4.19,;-5.9,-3.79,;-5.5,-2.3,;-4.73,.75,;-3.27,.27,;-2.36,1.52,;-3.27,2.77,;-4.73,2.29,;-.82,1.52,;-.05,.19,;-.05,2.85,;1.49,2.85,;2.26,4.19,;3.8,4.19,;4.57,2.85,;3.8,1.52,;2.26,1.52,;6.11,2.85,;7.01,4.1,;8.48,3.62,;8.48,2.08,;7.01,1.61,;6.24,.27,;7.78,.27,)|
Show InChI InChI=1S/C22H32N4O3S2/c1-15-19-14-20(30-22(19)26(24-15)18-6-3-2-4-7-18)21(27)23-16-8-10-17(11-9-16)25-12-5-13-31(25,28)29/h14,16-18H,2-13H2,1H3,(H,23,27)/t16-,17-
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 9.90n/an/an/an/a7.54



Daiichi Sankyo Company, Limited

US Patent


Assay Description
The PDE 7 (phosphodiesterase VII) inhibiting effect of the compounds of the present invention was performed by the following method, which was modifi...


US Patent US8901315 (2014)


BindingDB Entry DOI: 10.7270/Q2GM860P
More data for this
Ligand-Target Pair